Skip to main content

Table 1 Association between peritumoral lymphatic vessel density and clinicopathologic variables in oral squamous cell carcinomas. A.C.Camargo Cancer Hospital. São Paulo, Brazil

From: Association of lymph vessel density with occult lymph node metastasis and prognosis in oral squamous cell carcinoma

Variable

Peritumoral lymphatic vessel density

Sequential analysis

p value

Hot spot evaluation

p value

Low

High

Low

High

Gender

      

 Male

 Female

35 (77.8%)

10 (22.2%)

33 (78.6%)

09 (21.4%)

0.929

32 (76.2%)

10 (23.8%)

36 (80.0%)

09 (20.0%)

0.667

Ethnic group

      

 White

 Not white

40 (88.9%)

05 (11.1%)

40 (95.2%)

02 (4.8%)

0.435

37 (88.1%)

05 (11.9%)

43 (95.6%)

02 (4.4%)

0.255

Age

      

 ≤ 59 years

 > 59 years

22 (48.9%)

23 (51.1%)

23 (54.8%)

19 (45.2%)

0.584

21 (50.0%)

21 (50.0%)

24 (53.3%)

21 (46.7%)

0.756

Tobacco#

      

 No

 Yes

05 (11.9%)

37 (88.1%)

04 (10.3%)

35 (89.7%)

1.000

05 (13.2%)

33 (86.8%)

04 (9.3%)

39 (90.75)

0.728

Alcohol#

      

 No

 Yes

09 (21.4%)

33 (78.6%)

06 (15.4%)

33 (84.6%)

0.484

06 (15.8%)

32 (84.2%)

09 (20.9%)

34 (79.1%)

0.552

Tumor site

      

 Tongue

 Floor of mouth

30 (66.7%)

15 (33.3%)

30 (71.4%)

12 (28.6%)

0.631

31 (73.8%)

11 (26.2%)

29 (64.4%)

16 (35.6%)

0.345

T stage

      

 T1

 T2

12 (26.7%)

33 (73.3%)

16 (38.1%)

26 (61.9%)

0.254

12 (28.6%)

30 (71.4%)

16 (35.6%)

29 (64.4%)

0.486

Local recurrence

      

 No

 Yes

34 (75.6%)

11 (24.4%)

38 (90.5%)

04 (9.5%)

0.066

34 (81.0%)

08 (19.0%)

38 (84.4%)

07 (15.6%)

0.667

Regional recurrence

      

 No

 Yes

38 (84.4)

07 (15.6)

35 (83.3%)

07 (16.7%)

0.888

36 (85.7)

06 (14.3%)

37 (82.2%)

08 (17.8%)

0.658

Lymphatic embolization

      

 No

 Yes

30 (66.7%)

15 (33.3%)

32 (76.2%)

10 (23.8%)

0.327

28 (66.7%)

14 (33.3%)

34 (75.6%)

11 (24.4%)

0.360

Blood embolization

      

 No

 Yes

39 (86.7%)

06 (13.3%)

36 (85.7%)

06 (14.3%)

0.898

37 (88.1%)

05 (11.9%)

38 (84.4%)

07 (15.6%)

0.622

Perineural infiltration

      

 No

 Yes

18 (40.0%)

27 (60.0%)

25 (59,5%)

17 (40.5%)

0.069

16 (38.1%)

26 (61.9%)

27 (60.0%)

18 (40.0%)

0.041

Muscular infiltration

      

 No

 Yes

06 (13.3%)

39 (86.7%)

10 (23.8%)

32 (76.2%)

0.208

05 (11.9%)

37 (88.1%)

11 (24.4%)

34 (75.6%)

0.131

Salivary gland infiltration

      

 No

 Yes

25 (55.6%)

20 (44.4%)

33 (78.6%)

09 (21.4%)

0.230

27 (64.3%)

15 (35.7%)

31 (68.9%)

14 (31.1%)

0.649

Lymph-nodal status#

      

 pN0

 pN + 

30 (81.1%)

07 (18.9%)

20 (74.1%)

07 (25.9%)

0.503

26 (76.5%)

08 (23.5%)

24 (80.0%)

06 (20.0%)

0.733

Malignancy grading

      

 More differentiated

 Less differentiated

35 (77.8%)

10 (22.2%)

34 (81.0%)

08 (19.0%)

0.715

32 (76.2%)

10 (23.8%)

37 (82.2%)

08 (17.8%)

0.488

  1. # Excluding patients with lost records